Inhibitors for the adhesion of lymphocytes to glandular cells
    21.
    发明授权
    Inhibitors for the adhesion of lymphocytes to glandular cells 失效
    用于淋巴细胞粘附于腺细胞的抑制剂

    公开(公告)号:US6146630A

    公开(公告)日:2000-11-14

    申请号:US946838

    申请日:1997-10-08

    摘要: The present invention provides adhesion inhibitors for suppressing the adherence between E-cadherin of glandular cells and integrin of lymphocytes. Sjogren's syndrome comprises disorders wherein secretory glands such as lacrimal gland are destroyed by autoimmunity, and the adherence of CD8.sup.+ T cells to the surface of acinar cells is observed by the immunohistological analysis of lacrimal gland from patients. Integrin on the surface of T cells and E-cadherin on the surface of acinar cells play a major role in the mechanism of adhesion between these cells, while the adherence of T cells to acinar cells is reduced using anti-E-cadherin and anti-integrin antibodies. Sjogren's syndrome, such as autoimmune adenitis, can be treated using these antibodies.

    摘要翻译: 本发明提供了抑制腺细胞的E-钙粘蛋白与淋巴细胞的整联蛋白之间粘附的粘合抑制剂。 Sj + E,cir o + EE gren综合征包括其中分泌腺如泪腺被自身免疫破坏的疾病,并且通过对患者的泪腺的免疫组织学分析观察到CD8 + T细胞对腺泡细胞表面的粘附。 在腺泡细胞表面的T细胞和E-钙粘蛋白表面的整合素在这些细胞之间的粘附机制中起主要作用,而使用抗E-钙粘蛋白和抗E-钙粘蛋白减少T细胞对腺泡细胞的粘附, 整合素抗体。 可以使用这些抗体治疗Sj + E,cir o + EE gren综合征,例如自身免疫性腺炎。